Comparative Anti-Inflammatory Profile of Some Cytisine and Tetrahydroisoquinoline Derivatives: Interactions with COX-2 and Histamine H1 Receptors
Scientia Pharmaceutica · 20.10.2026 · 94 (4) · 99
DOI: 10.3390/scipharm94040099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientia Pharmaceutica, online erschienen am 20.10.2026. Verfasst von Azizbek A. Azamatov und 9 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Accumulating evidence indicates extensive crosstalk between prostaglandin- and histamine-mediated signaling pathways. Histamine has been shown to induce COX-2 (Cyclooxygenase-2) expression and stimulate prostaglandin synthesis, whereas prostaglandins potentiate the vascular and inflammatory effects of histamine, creating a positive feedback loop that sustains inflammation. Based on these considerations, in silico molecular docking study of interaction of new cytisine and TGIQ (tetrahydroisoquinoline) derivatives with COX-2 and the histamine H1 receptor was performed. Among the synthesized compounds, compound 1 exhibited the highest binding affinity toward Cyclooxygenase-2 (COX-2). Within the binding pocket of the human H1 histamine receptor, the binding affinity profile differed markedly from that observed for COX-2, with compound 4 exhibiting the highest therapeutic potential and the strongest binding affinity, surpassing all reference compounds. The high anti-inflammatory efficacy of the studied compounds was confirmed in formalin- and histamine rat models. THIQ derivatives were shown to possess a higher anti-inflammatory index than cytisine derivatives. Comparative evaluation of the anti-inflammatory activity of isoquinoline and quinolizidine derivatives revealed that the isoquinoline derivatives possess marked anti-inflammatory properties combined with low toxicity, making them promising candidates for the development of novel, highly effective and safe anti-inflammatory agents for both oral and topical administration.
Zitieren
APA
Azamatov, A. A., Miskinova, F. K., Kurbonov, U. A., Zhurakulov, S. N., Kuchimov, K. F., Ergasheva, M. J., Boboev, Z. D., Abdurazakova, R. S., Shukurlaev, K. S., & Vinogradova, V. I. (2026). Comparative Anti-Inflammatory Profile of Some Cytisine and Tetrahydroisoquinoline Derivatives: Interactions with COX-2 and Histamine H1 Receptors. Scientia Pharmaceutica, 94(4), 99. https://doi.org/10.3390/scipharm94040099
Vancouver
Azamatov AA, Miskinova FK, Kurbonov UA, Zhurakulov SN, Kuchimov KF, Ergasheva MJ, et al. Comparative Anti-Inflammatory Profile of Some Cytisine and Tetrahydroisoquinoline Derivatives: Interactions with COX-2 and Histamine H1 Receptors. Scientia Pharmaceutica. 2026;94(4):99. doi:10.3390/scipharm94040099
BibTeX
@article{Azamatov2026,
author = {Azamatov, Azizbek A. and Miskinova, Fazilat Kh. and Kurbonov, Ulugbek A. and Zhurakulov, Sherzod N. and Kuchimov, Kuvonchbek F. and Ergasheva, Mukaramoy J. and Boboev, Zufar D. and Abdurazakova, Robiya S. and Shukurlaev, Kadir S. and Vinogradova, Valentina I.},
title = {Comparative Anti-Inflammatory Profile of Some Cytisine and Tetrahydroisoquinoline Derivatives: Interactions with COX-2 and Histamine H1 Receptors},
journal = {Scientia Pharmaceutica},
year = {2026},
volume = {94},
number = {4},
pages = {99},
doi = {10.3390/scipharm94040099}
}
EUVIMED